User menu

Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium

Bibliographic reference Ducreux, Julie ; Durez, Patrick ; Galant, Christine ; Nzeusseu Toukap, Adrien ; Van den Eynde, Benoît ; et. al. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. In: Arthritis & rheumatology (Hoboken, N.J.), Vol. 66, no. 1, p. 15-23 (2014)
Permanent URL http://hdl.handle.net/2078.1/145875
  1. Maini R. N., Taylor P. C., Szechinski J., Pavelka K., Bröll J., Balint G., Emery P., Raemen F., Petersen J., Smolen J., Thomson D., Kishimoto T., , Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate, 10.1002/art.22033
  2. Smolen Josef S, Beaulieu Andre, Rubbert-Roth Andrea, Ramos-Remus Cesar, Rovensky Josef, Alecock Emma, Woodworth Thasia, Alten Rieke, Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial, 10.1016/s0140-6736(08)60453-5
  3. Genovese Mark C., McKay James D., Nasonov Evgeny L., Mysler Eduardo F., da Silva Nilzio A., Alecock Emma, Woodworth Thasia, Gomez-Reino Juan J., Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study, 10.1002/art.23940
  4. Badot Valérie, Galant Christine, Nzeusseu Toukap Adrien, Theate Ivan, Maudoux Anne-Lise, Van den Eynde Benoît J, Durez Patrick, Houssiau Frédéric A, Lauwerys Bernard R, Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis, 10.1186/ar2678
  5. Gutierrez-Roelens I., Galant C., Theate I., Lories R. J., Durez P., Nzeusseu-Toukap A., Van den Eynde B., Houssiau F. A., Lauwerys B. R., Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium, 10.1002/art.30292
  6. Arnett Frank C., Edworthy Steven M., Bloch Daniel A., Mcshane Dennis J., Fries James F., Cooper Norman S., Healey Louis A., Kaplan Stephen R., Liang Matthew H., Luthra Harvinder S., Medsger Thomas A., Mitchell Donald M., Neustadt David H., Pinals Robert S., Schaller Jane G., Sharp John T., Wilder Ronald L., Hunder Gene G., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, 10.1002/art.1780310302
  7. Prevoo M. L. L., Van'T Hof M. A., Kuper H. H., Van Leeuwen M. A., Van De Putte L. B. A., Van Riel P. L. C. M., Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis : MODIFIED DISEASE ACTIVITY SCORE, 10.1002/art.1780380107
  8. Smolen J. S., Breedveld F. C., Schiff M. H., Kalden J. R., Emery P., Eberl G., van Riel P. L., Tugwell P., A simplified disease activity index for rheumatoid arthritis for use in clinical practice, 10.1093/rheumatology/keg072
  9. van Gestel A. M., Prevoo M. L. L., van't Hof M. A., van Rijswijk M. H., van de Putte L. B. A., van Riel P. L. C. M., Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria, 10.1002/art.1780390105
  10. Boyle David L, Rosengren Sanna, Bugbee William, Kavanaugh Arthur, Firestein Gary S, 10.1186/ar1004
  11. Gerlag Daniëlle M., Tak Paul P., How to perform and analyse synovial biopsies, 10.1016/j.berh.2009.01.006
  12. Toukap A. Nzeusseu, Galant C., Theate I., Maudoux A. L., Lories R. J. U., Houssiau F. A., Lauwerys B. R., Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus, 10.1002/art.22578
  13. Irizarry R. A., Exploration, normalization, and summaries of high density oligonucleotide array probe level data, 10.1093/biostatistics/4.2.249
  14. Huang Da Wei, Sherman Brad T, Lempicki Richard A, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, 10.1038/nprot.2008.211
  15. Aletaha, Clin Exp Rheumatol, 23, S100 (2005)
  16. Lipsky Peter E, 10.1186/ar1918
  17. Houssiau Frédéric A., Devogelaer Jean-Pierre, Damme Jo Van, Deuxchaisnes Charles Nagant De, Snick Jacques Van, Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides, 10.1002/art.1780310614
  18. Houssiau FrédéRic A., Coulie Pierre G., Olive Daniel, Snick Jacques Van, Synergistic activation of human t cells by interleukin 1 and interleukin 6, 10.1002/eji.1830180427
  19. Houssiau, J Immunol, 143, 2520 (1989)
  20. Bettelli Estelle, Carrier Yijun, Gao Wenda, Korn Thomas, Strom Terry B., Oukka Mohamed, Weiner Howard L., Kuchroo Vijay K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, 10.1038/nature04753
  21. Field M., Chu C., Feldmann M., Maini R. N., Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis, 10.1007/bf00291144
  22. van de Veerdonk Frank L., Lauwerys Bernard, Marijnissen Renoud J., Timmermans Kim, Di Padova Franco, Koenders Marije I., Gutierrez-Roelens Ilse, Durez Patrick, Netea Mihai G., van der Meer Jos W. M., van den Berg Wim B., Joosten Leo A. B., The anti-CD20 antibody rituximab reduces the Th17 cell response, 10.1002/art.30314
  23. You Sungyong, Cho Chul-Soo, Lee Inyoul, Hood Leroy, Hwang Daehee, Kim Wan-Uk, A Systems Approach to Rheumatoid Arthritis, 10.1371/journal.pone.0051508
  24. Isaacs John D, Cohen Stanley B, Emery Paul, Tak Paul P, Wang Jianmei, Lei Guiyuan, Williams Sarah, Lal Preeti, Read Simon J, Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis, 10.1136/annrheumdis-2011-201117
  25. Dougados Maxime, Kissel Karsten, Sheeran Tom, Tak Paul P, Conaghan Philip G, Mola Emilio Martín, Schett Georg, Amital Howard, Navarro-Sarabia Federico, Hou Antony, Bernasconi Corrado, Huizinga TWJ, Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY), 10.1136/annrheumdis-2011-201282
  26. Klareskog Lars, van der Heijde Désirée, de Jager Julien P, Gough Andrew, Kalden Joachim, Malaise Michel, Mola Emilio Martín, Pavelka Karel, Sany Jacques, Settas Lucas, Wajdula Joseph, Pedersen Ronald, Fatenejad Saeed, Sanda Marie, Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial, 10.1016/s0140-6736(04)15640-7